222 related articles for article (PubMed ID: 8186889)
1. FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.
Perez-Bacete MJ; Llombart-Bosch A
Virchows Arch; 1994; 424(3):243-7. PubMed ID: 8186889
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma.
Fletcher CD
Am J Surg Pathol; 1992 Mar; 16(3):213-28. PubMed ID: 1317996
[TBL] [Abstract][Full Text] [Related]
3. [Current topics in the diagnosis and treatment of malignant fibrous histiocytoma].
Chuman H
Gan To Kagaku Ryoho; 2003 May; 30(5):626-33. PubMed ID: 12795093
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
[TBL] [Abstract][Full Text] [Related]
5. [Malignant fibrous histiocytoma: pleomorphic sarcoma NOS or pleomorphic fibrosarcoma].
Meister P
Pathologe; 2005 Mar; 26(2):127-33. PubMed ID: 15702318
[TBL] [Abstract][Full Text] [Related]
6. Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies.
Iwasaki H; Isayama T; Johzaki H; Kikuchi M
Am J Pathol; 1987 Sep; 128(3):528-37. PubMed ID: 2820234
[TBL] [Abstract][Full Text] [Related]
7. [Reassessment of the pathological diagnosis in 33 cases of malignant fibrous histiocytoma].
Guo H; Xiong Y; Nong L; Zhang S; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):374-9. PubMed ID: 18677383
[TBL] [Abstract][Full Text] [Related]
8. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
9. [Imprint cytological features of soft tissue sarcomas].
Sonobe H
Rinsho Byori; 1999 Jul; 47(7):614-21. PubMed ID: 10442039
[TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
[TBL] [Abstract][Full Text] [Related]
11. Metastases of malignant melanoma simulating soft tissue sarcoma. A clinico-pathological, light- and electron microscopic and immunohistochemical study of 21 cases.
Lodding P; Kindblom LG; Angervall L
Virchows Arch A Pathol Anat Histopathol; 1990; 417(5):377-88. PubMed ID: 2173252
[TBL] [Abstract][Full Text] [Related]
12. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68).
Binder SW; Said JW; Shintaku IP; Pinkus GS
Am J Clin Pathol; 1992 Jun; 97(6):759-63. PubMed ID: 1317667
[TBL] [Abstract][Full Text] [Related]
13. Osteogenic sarcoma. Malignant fibrous histiocytoma subtype.
Ballance WA; Mendelsohn G; Carter JR; Abdul-Karim FW; Jacobs G; Makley JT
Cancer; 1988 Aug; 62(4):763-71. PubMed ID: 2840191
[TBL] [Abstract][Full Text] [Related]
14. Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p.
Sabah M; Cummins R; Leader M; Kay E
Virchows Arch; 2005 Mar; 446(3):251-8. PubMed ID: 15731925
[TBL] [Abstract][Full Text] [Related]
15. [Pathology and histology of soft tissue sarcomas in the upper extremity: adults].
Katenkamp D
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):263-7. PubMed ID: 15503255
[TBL] [Abstract][Full Text] [Related]
16. [An analysis of autopsy cases of malignant soft tissue and bone tumors].
Enjoji M; Hashimoto H; Yamamoto I; Daimaru Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1931-6. PubMed ID: 2543328
[TBL] [Abstract][Full Text] [Related]
17. Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis.
Randall RL; Albritton KH; Ferney BJ; Layfield L
Am J Orthop (Belle Mead NJ); 2004 Dec; 33(12):602-8. PubMed ID: 15641745
[TBL] [Abstract][Full Text] [Related]
18. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
[TBL] [Abstract][Full Text] [Related]
19. From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation.
Murphey MD; Gross TM; Rosenthal HG
Radiographics; 1994 Jul; 14(4):807-26; quiz 827-8. PubMed ID: 7938770
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR (Ia-like) reactivity in tumors of bone and soft tissue: an immunohistochemical comparison of monoclonal antibodies LN3 and LK8D3 in routinely processed specimens.
Swanson PE; Wick MR
Mod Pathol; 1990 Mar; 3(2):113-9. PubMed ID: 1691491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
